Olgotrelvir for COVID-19: real-time analysis

Download Image

Post

c19early.org

Olgotrelvir for COVID-19

1 study with >1,000 patients

Serious outcome risk

Olgotrelvir

Control

Significantly lower risk for recovery.

COVID-19 Olgotrelvir studies · October 2026

Outcome (studies)

Improvement

Relative risk · 95% CI

All studies (1)67%

Hospitalization (1)67%

RCTs (1)67%

Early (1)67%

00.511.5+

← Olgotrelvir
reduces riskIncreased
risk →

.hmva--anim-stagger .hmva__row{opacity:1}.hmva--anim .hmva__shade{opacity:var(--shade-opacity)}.hmva--anim-stagger .est .ci{transform:translateY(-50%)}.hmva--anim-stagger .est .pt{transform:translate(-50%,-50%)}.hmva--anim-stagger .hmva__bar{transform:none}.hmva--anim-settle .est .pt{left:calc(min(var(--pt), 1.5) / var(--max) * 100%)}.hmva--anim-settle .est .ci{left:calc(var(--lo) / var(--max) * 100%);width:calc((var(--hi) - var(--lo)) / var(--max) * 100%)}.hmva--anim-settle .hmva__bar--drug{width:calc(min(1, var(--rr)) * 100%)}.hmva--anim-settle .hmva__bar--control{width:calc(min(1, 1 / var(--rr)) * 100%)}


May 28 2024	Jiang et al., NEJM Evidence, doi:10.1056/EVIDoa2400026	Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19
May 28 2024	22% improved recovery (p=0.0001). RCT 1,212 outpatients with mild to moderate COVID-19 showing faster recovery with olgotrelvir.